When Izzy’s ‘Pops’, who had lived with Parkinson’s for more than a decade, lost his ability to write, she and her friend ...

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

The Global Insulin Pump Market achieved a valuation of $5.90 Billion in 2024 and is anticipated to exceed $14.49 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 8.55% during the ...

With diabetes, the body is unable to produce or use the hormone insulin as it should, which results in high blood glucose levels. Although they’re not fundamentally linked, UC and diabetes ...

While weight loss medications can deliver significant results, our bodies eventually adapt to everything. And many people end ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

CBSE allows students with Type 1 diabetes to carry insulin pumps and glucometers, highlighting the need for paediatric ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...

The global disposable insulin-delivery device market is projected to experience robust growth over the next decade, according to recent industry insights. Valued at USD 14,585.6 million in 2022, the ...

The warning comes just six months after the TGA issued a separate alert for counterfeit Ozempic injection pens containing insulin. The TGA warned fake injection pens may pose serious heath risks.

The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the price of insulin — a drug millions of Americans need to survive. When it did, ...